Increased risk of benign prostatic enlargement among patients with liver cirrhosis

A nationwide population-based study

Shiu Dong Chung, Herng Ching Lin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There have been several post mortem studies focusing on the association between liver cirrhosis and benign prostate hyperplasia; however, the results are controversial. The aim of this study was to estimate the risk of benign prostatic enlargement during a 5-year follow-up period following a liver cirrhosis diagnosis, using nationwide population-based data and a retrospective cohort design. We used the "Longitudinal Health Insurance Database," derived from the Taiwan National Health Insurance program. The study cohort comprised 661 patients who had received treatment for liver cirrhosis between 1997 and 2001; the comparison cohort was composed of 3305 randomly selected patients. Stratified Cox proportional hazard regressions were performed as a means of comparing the 5-year benign prostatic enlargement survival rate for the 2 cohorts. Of the sampled patients, 808 patients (20.4%) developed benign prostatic enlargement during the follow-up period (ie, 163 individuals from the study cohort [24.7% of the patients with liver cirrhosis] and 645 individuals from the comparison cohort [19.5% of comparison cohort patients]). The log-rank test indicated that patients with liver cirrhosis had significantly lower 5-year benign prostatic enlargement-free survival rates than the controls (P, .001). The adjusted hazard ratios for benign prostatic enlargement following diagnosis with liver cirrhosis were 1.41 during the 5-year follow-up period. We conclude that the risk for benign prostatic enlargement increased after a diagnosis of liver cirrhosis. Further studies are needed to identify the underlying pathophysiology.

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalJournal of Andrology
Volume32
Issue number2
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

Fingerprint

Liver Cirrhosis
Population
National Health Programs
Cohort Studies
Survival Rate
Health Insurance
Taiwan
Hyperplasia
Prostate
Databases

Keywords

  • Lower urinary tract symptoms
  • Prostate
  • Voiding

ASJC Scopus subject areas

  • Urology
  • Reproductive Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Increased risk of benign prostatic enlargement among patients with liver cirrhosis : A nationwide population-based study. / Chung, Shiu Dong; Lin, Herng Ching.

In: Journal of Andrology, Vol. 32, No. 2, 03.2011, p. 159-164.

Research output: Contribution to journalArticle

@article{18f1c4171a6d4baa9bcb25522e1fad4b,
title = "Increased risk of benign prostatic enlargement among patients with liver cirrhosis: A nationwide population-based study",
abstract = "There have been several post mortem studies focusing on the association between liver cirrhosis and benign prostate hyperplasia; however, the results are controversial. The aim of this study was to estimate the risk of benign prostatic enlargement during a 5-year follow-up period following a liver cirrhosis diagnosis, using nationwide population-based data and a retrospective cohort design. We used the {"}Longitudinal Health Insurance Database,{"} derived from the Taiwan National Health Insurance program. The study cohort comprised 661 patients who had received treatment for liver cirrhosis between 1997 and 2001; the comparison cohort was composed of 3305 randomly selected patients. Stratified Cox proportional hazard regressions were performed as a means of comparing the 5-year benign prostatic enlargement survival rate for the 2 cohorts. Of the sampled patients, 808 patients (20.4{\%}) developed benign prostatic enlargement during the follow-up period (ie, 163 individuals from the study cohort [24.7{\%} of the patients with liver cirrhosis] and 645 individuals from the comparison cohort [19.5{\%} of comparison cohort patients]). The log-rank test indicated that patients with liver cirrhosis had significantly lower 5-year benign prostatic enlargement-free survival rates than the controls (P, .001). The adjusted hazard ratios for benign prostatic enlargement following diagnosis with liver cirrhosis were 1.41 during the 5-year follow-up period. We conclude that the risk for benign prostatic enlargement increased after a diagnosis of liver cirrhosis. Further studies are needed to identify the underlying pathophysiology.",
keywords = "Lower urinary tract symptoms, Prostate, Voiding",
author = "Chung, {Shiu Dong} and Lin, {Herng Ching}",
year = "2011",
month = "3",
doi = "10.2164/jandrol.110.011163",
language = "English",
volume = "32",
pages = "159--164",
journal = "Journal of Andrology",
issn = "0196-3635",
publisher = "American Society of Andrology Inc.",
number = "2",

}

TY - JOUR

T1 - Increased risk of benign prostatic enlargement among patients with liver cirrhosis

T2 - A nationwide population-based study

AU - Chung, Shiu Dong

AU - Lin, Herng Ching

PY - 2011/3

Y1 - 2011/3

N2 - There have been several post mortem studies focusing on the association between liver cirrhosis and benign prostate hyperplasia; however, the results are controversial. The aim of this study was to estimate the risk of benign prostatic enlargement during a 5-year follow-up period following a liver cirrhosis diagnosis, using nationwide population-based data and a retrospective cohort design. We used the "Longitudinal Health Insurance Database," derived from the Taiwan National Health Insurance program. The study cohort comprised 661 patients who had received treatment for liver cirrhosis between 1997 and 2001; the comparison cohort was composed of 3305 randomly selected patients. Stratified Cox proportional hazard regressions were performed as a means of comparing the 5-year benign prostatic enlargement survival rate for the 2 cohorts. Of the sampled patients, 808 patients (20.4%) developed benign prostatic enlargement during the follow-up period (ie, 163 individuals from the study cohort [24.7% of the patients with liver cirrhosis] and 645 individuals from the comparison cohort [19.5% of comparison cohort patients]). The log-rank test indicated that patients with liver cirrhosis had significantly lower 5-year benign prostatic enlargement-free survival rates than the controls (P, .001). The adjusted hazard ratios for benign prostatic enlargement following diagnosis with liver cirrhosis were 1.41 during the 5-year follow-up period. We conclude that the risk for benign prostatic enlargement increased after a diagnosis of liver cirrhosis. Further studies are needed to identify the underlying pathophysiology.

AB - There have been several post mortem studies focusing on the association between liver cirrhosis and benign prostate hyperplasia; however, the results are controversial. The aim of this study was to estimate the risk of benign prostatic enlargement during a 5-year follow-up period following a liver cirrhosis diagnosis, using nationwide population-based data and a retrospective cohort design. We used the "Longitudinal Health Insurance Database," derived from the Taiwan National Health Insurance program. The study cohort comprised 661 patients who had received treatment for liver cirrhosis between 1997 and 2001; the comparison cohort was composed of 3305 randomly selected patients. Stratified Cox proportional hazard regressions were performed as a means of comparing the 5-year benign prostatic enlargement survival rate for the 2 cohorts. Of the sampled patients, 808 patients (20.4%) developed benign prostatic enlargement during the follow-up period (ie, 163 individuals from the study cohort [24.7% of the patients with liver cirrhosis] and 645 individuals from the comparison cohort [19.5% of comparison cohort patients]). The log-rank test indicated that patients with liver cirrhosis had significantly lower 5-year benign prostatic enlargement-free survival rates than the controls (P, .001). The adjusted hazard ratios for benign prostatic enlargement following diagnosis with liver cirrhosis were 1.41 during the 5-year follow-up period. We conclude that the risk for benign prostatic enlargement increased after a diagnosis of liver cirrhosis. Further studies are needed to identify the underlying pathophysiology.

KW - Lower urinary tract symptoms

KW - Prostate

KW - Voiding

UR - http://www.scopus.com/inward/record.url?scp=80455158235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455158235&partnerID=8YFLogxK

U2 - 10.2164/jandrol.110.011163

DO - 10.2164/jandrol.110.011163

M3 - Article

VL - 32

SP - 159

EP - 164

JO - Journal of Andrology

JF - Journal of Andrology

SN - 0196-3635

IS - 2

ER -